TGF-β in renal injury and disease

被引:321
作者
Bottinger, Erwin P. [1 ]
机构
[1] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
关键词
fibrosis; chronic kidney disease; cell biology; signal transduction; apoptosis;
D O I
10.1016/j.semnephrol.2007.02.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Chronic progressive kidney diseases typically are characterized by loss of differentiated epithelial cells and activation of mesenchymal cell populations leading to renal fibrosis in response to a broad range of diverse renal injuries. Recent evidence has indicated that epithelial microinjury leads to unbalanced epithelial-mesenchymal communication to initiate the fibrotic response. Transforming growth factors beta constitute a large family of cytokines that control key cellular responses in development and tissue repair. Activation of autocrine and paracrine transforming growth factor-beta signaling cascades in the context of epithelial microinjuries initiate a variety of cell type- dependent signaling and activity profiles, including epithelial apoptosis and epithelial-to-mesenchymal transition, that trigger fibrogenic foci and initiate progressive fibrogenesis in chronic renal injury.
引用
收藏
页码:309 / 320
页数:12
相关论文
共 123 条
  • [1] INTRAGLOMERULAR HYPERTENSION - IMPLICATIONS AND DRUG-TREATMENT
    ANDERSON, S
    BRENNER, BM
    [J]. ANNUAL REVIEW OF MEDICINE, 1988, 39 : 243 - 253
  • [2] THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT
    ANDERSON, S
    RENNKE, HG
    BRENNER, BM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) : 1993 - 2000
  • [3] Transforming growth factor-beta(1) is a potent inhibitor of glutathione synthesis in the lung epithelial cell line A549: Transcriptional effect on the GSH rate-limiting enzyme gamma-glutamylcysteine synthetase
    Arsalane, K
    Dubois, CM
    Muanza, T
    Begin, R
    Boudreau, F
    Asselin, C
    Cantin, AM
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (05) : 599 - 607
  • [4] Bitzer M, 2000, GENE DEV, V14, P187
  • [5] Transforming growth factor-β in renal disease
    Bitzer, M
    Sterzel, RB
    Böttinger, EP
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 1998, 21 (01) : 1 - 12
  • [6] SUPPRESSION OF EXPERIMENTAL GLOMERULONEPHRITIS BY ANTISERUM AGAINST TRANSFORMING GROWTH FACTOR-BETA-1
    BORDER, WA
    OKUDA, S
    LANGUINO, LR
    SPORN, MB
    RUOSLAHTI, E
    [J]. NATURE, 1990, 346 (6282) : 371 - 374
  • [7] NATURAL INHIBITOR OF TRANSFORMING GROWTH-FACTOR-BETA PROTECTS AGAINST SCARRING IN EXPERIMENTAL KIDNEY-DISEASE
    BORDER, WA
    NOBLE, NA
    YAMAMOTO, T
    HARPER, JR
    YAMAGUCHI, Y
    PIERSCHBACHER, MD
    RUOSLAHTI, E
    [J]. NATURE, 1992, 360 (6402) : 361 - 364
  • [8] BORDER WA, 1994, NEW ENGL J MED, V331, P1286
  • [9] Lessons from TGF-β transgenic mice
    Böttinger, EP
    Kopp, JB
    [J]. MINERAL AND ELECTROLYTE METABOLISM, 1998, 24 (2-3) : 154 - 160
  • [10] TGF-β signaling in renal disease
    Böttinger, EP
    Bitzer, M
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (10): : 2600 - 2610